New methods to treat a specific type of ovarian cancer
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
This study is looking at a tough type of ovarian cancer called high-grade serous tubo-ovarian carcinoma to find out why it often doesn't respond to regular treatments, and it's testing new therapy combinations to help improve outcomes for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11001564 on NIH RePORTER |
What this research studies
This research focuses on high-grade serous tubo-ovarian carcinoma (HGSC), a form of ovarian cancer that often resists standard treatments. The team is developing advanced models to better understand the genetic factors that contribute to this resistance, particularly the amplification of the CCNE1 gene. By creating organoid models that mimic human cancer, they aim to test new combinations of therapies, including chemotherapy and immunotherapy, to improve treatment outcomes for patients with this aggressive cancer. The research involves collaboration among experts in cancer biology and genomics to ensure a comprehensive approach to tackling this challenging disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with high-grade serous tubo-ovarian carcinoma, particularly those with CCNE1 amplification.
Not a fit: Patients with other types of ovarian cancer or those who are not platinum-resistant may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with platinum-resistant ovarian cancer.
How similar studies have performed: Other research has shown promise in using organoid models to study cancer, indicating that this approach could yield valuable insights.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Neel, Benjamin G. — New York University School of Medicine
- Study coordinator: Neel, Benjamin G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.